As the first company in Europe, Bioceltix intends to authorize a veterinary biopharmaceutical based on stem cells. Łukasz Bzdzion, the CEO of the startup we talked to at the Impact’18 congress, tells about the advantages of Polish technology over those that are currently in use – Business Insdier Polska.
